The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
NK cells are an attractive target for cancer immunotherapy due to their potent antitumor activity. The main advantage of using NK cells as cytotoxic effectors over T cells is a reduced risk of graft versus host disease. At present, several variants of NK-cell-based therapies are undergoing clinical...
Enregistré dans:
Auteurs principaux: | Rodion A. Velichinskii, Maria A. Streltsova, Sofya A. Kust, Alexander M. Sapozhnikov, Elena I. Kovalenko |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/83ca3865322b4cc78ed811691b3cbe1c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
par: Lara Herrera, et autres
Publié: (2021) -
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
par: Zhengli Xu, et autres
Publié: (2021) -
The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy
par: Elena V. Abakushina, et autres
Publié: (2021) -
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
par: Erica L. Heipertz, et autres
Publié: (2021) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
par: Sergey Kulemzin, et autres
Publié: (2021)